Notice Title

Consent to the Distribution of New Medicines

Publication Date
22 Sep 2022

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2022-go3978
Title
View PDF
File Type and Size
PDF (38 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Dizole 50
Active Ingredient: Fluconazole 50mg
Dosage Form: Capsule
New Zealand Sponsor: Viatris Limited
Manufacturer: Mylan Laboratories Limited, Nashik, India
   
Product: Mersynofen (Pharmacy Only)
Active Ingredients: Ibuprofen 200mg
Paracetamol 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Sanofi Vietnam Shareholding Company, Ho Chi Minh City, Vietnam
   
Product: Mersynofen (General Sale)
Active Ingredients: Ibuprofen 200mg
Paracetamol 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Sanofi Vietnam Shareholding Company, Ho Chi Minh City, Vietnam
   
Product: Phesgo
Active Ingredients: Pertuzumab 60mg/mL
Trastuzumab 60mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturer: F. Hoffmann-La Roche Limited, Kaiseraugst, Switzerland
   
Product: Phesgo
Active Ingredients: Pertuzumab 80mg/mL
Trastuzumab 40mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturer: F. Hoffmann-La Roche Limited, Kaiseraugst, Switzerland
   
Product: Spy Agent Green
Active Ingredient: Indocyanine green 25mg
Dosage Form: Powder for injection
New Zealand Sponsor: Stryker New Zealand Limited
Manufacturer: Patheon Italia SpA, 2° Trav. SX V, Ferentino, Italy
   
Product: Yuflyma (Pre-filled syringe)
Active Ingredient: Adalimumab 100mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Celltrion Healthcare New Zealand Limited
Manufacturer: Catalent Belgium SA, Brussels, Belgium
   
Product: Yuflyma (Pre-filled syringe with needle guard)
Active Ingredient: Adalimumab 100mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Celltrion Healthcare New Zealand Limited
Manufacturer: Catalent Belgium SA, Brussels, Belgium
   
Product: Yuflyma (Pre-filled pen)
Active Ingredient: Adalimumab 100mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Celltrion Healthcare New Zealand Limited
Manufacturer: Catalent Belgium SA, Brussels, Belgium


Dated this 16th day of September 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).